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Abstract
Background: Women at high-risk of developing breast cancer must be screened appropriately
and educated about breast cancer reduction strategies much earlier than those of average risk.
The National Comprehensive Cancer Network (NCCN) (2017) has identified guidelines for the
care of this group. While some primary care providers (PCPs) are well informed about high-risk
and how to identify it, many are not. This project focuses on the development of education for
providers, specifically an eLearning module, to help translate guidelines into practice.
Methods: Providers of adult primary care (including internal medicine and family practice) from
four clinics in Snohomish County, Washington, were asked to participate in an eLearning
module regarding the care of patients at high-risk for breast cancer. The module was developed
using the Microsoft Mix platform and a link was sent out to primary care providers via email
during a thirty-day period. Data was collected and analyzed using the Kirkpatrick Method to
evaluate the objectives related to reaction, learning, behavior and results through a pretest survey
and two posttests surveys (one immediately following the module and another approximately
thirty days following the opening of the module) to determine if the objectives were achieved.
Results: Repeated measures surveys using a Likert Scale were presented to the PCP participants,
as well as questions regarding demographics and current practices. The surveys assessed the
four components of learning according to the Kirkpatrick Model including reaction, knowledge,
behavior and results. Twenty-three providers (22.3%) responded and reacted positively to this
learning format. All participants reacted favorably to questions regarding reaction, with greater
than 50% answering “strongly agree” or “agree”. Paired t-tests were used to evaluate learning
regarding knowledge and behavior, showing statistically significant improvement (sig. < 0.05)
between pretest and posttest for questions about understanding current evidence-based
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recommendations, use of a screening tool, and referrals to a breast care specialist, supporting
that learning occurred and participants believed this learning would impact their behaviors.
Results after one month were weak, with participation in the follow-up survey to be ten
providers, however 60% were inclined to provide a more individualized approach to high-risk
assessments, and 80% were more aware of the specialized care available to reduce the burden of
high-risk care from their practices. The use of a screening tool, as well as collaboration with
experts, were two categories that remained neutral or showed little positive impact, however to
truly evaluate these practices, a longer study would be beneficial.
Implications for practice: High-risk breast education is needed for the PCP to engage in shared
decision-making with their patients about high risk care.
Conclusions: Patients at high-risk for developing breast cancer should be evaluated more
frequently to prevent cancer. The USPSTF does not set guidelines for mammography of patients
who are at high-risk. The NCCN (2016) has created evidence-based guidelines for the support
and monitoring of patients who are found to be at high-risk; however, this evidence continues to
be slowly disseminated.

Keywords: High-risk, breast cancer, provider education, education module, internetbased learning
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Managing Patients at High-risk for Breast Cancer: A Learning Module for Primary Care
Providers
Introduction
When making recommendations to patients about when they should be receiving their
annual mammograms, it is often confusing for providers because various bodies of knowledge
continue to disagree. For women of average risk, The American Cancer Society (ACS), The
American College of Radiology (ACR), The American College of Gynecology (ACOG) and The
United States Preventative Services Task Force (USPSTF) do not agree on the starting age and
frequency women should receive mammograms. A majority of providers across the nation
choose to follow the USPSTF recommendation who state that women should receive
mammograms every two years after age 50-years until the age of 74-years (USPSTF, 2016).
This recommendation differs from those of the ACS (2017) who recommend yearly
mammography starting at age 45-years, and the ACR (2017) and ACOG (2017) who recommend
yearly mammography starting at age 40-years. In the midst of confusion about what is the best
recommendation to follow for mammography, more recent evidence based recommendations
regarding identification and management of patients at higher risk have not been uniformly
translated into primary care. This project focuses on educating primary care providers (PCPs)
about recommendations for patients at high-risk for developing breast cancer, so that they can
better educate their patients and facilitate shared decision-making about appropriate preventative
care.
Background
Evidence indicates that persons of higher risk must be screened appropriately and
educated about breast cancer risk reduction strategies earlier than persons at average risk. The
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high-risk category includes persons who have a strong familial history of breast and ovarian
cancer, women with dense breast tissue, and those with genetic predisposition (Raikhlin et al.,
2015). It is estimated that 86% of women over twenty years of age who have the BRCA1 and/ or
BRCA2 gene mutations are unaware (Drohan, Roche, Cusack, & Hughes, 2012). Additionally,
in recent years, several new genetic mutations linked to breast cancer have been identified. The
guidelines created by the National Comprehensive Cancer Network (NCCN) (2017) for women
at high-risk are more rigorous and include increased screening every six months alternating both
mammography and magnetic resonance imaging (MRI), biannual breast examination by a breast
care provider, and, where appropriate, genetic testing. The consensus is that use of magnetic
resonance imaging (MRI) is the most sensitive imaging modality in identifying cancer in earlier
stages, when compared to using mammography alone (Berg et al., 2012).
Furthermore, breast density is quickly becoming a recognized risk factor for breast
cancer, however women generally do not know whether they have dense breast tissue until their
first mammogram. Thirty states have enacted laws requiring that breast density information be
given to the patient following mammography (Vroomen, 2017), however Washington State is
currently in process to do so. The ACR (2014) supports that increased breast density may
interfere with the detection of breast cancer and that is likely increases the risk of breast cancer,
although breast tomosynthesis (3D imaging) mammography is improving the imaging of dense
tissue.
The NCCN (2017) guidelines are specific regarding the care of women with a greater
than 20% lifetime risk, which often includes women under the age of 40-years. Unfortunately, at
this time, these guidelines have not been translated into primary care practice very well. While
some primary care providers are very well informed about what qualifies a patient as high-risk,
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others remain unsure. Even when they are able to identify risk, they do not know how to manage
or where to send these patients for further evaluation because high-risk breast programs are just
beginning to emerge into mainstream health care.
The evidence-based guidelines that are in place to provide specialized care for these
patients, however guidelines have not yet been well integrated into practice. Providers need to
be aware of what can be done to deliver optimal preventative care, or at the very least, how to
appropriately screen and refer those most at risk. While high-risk breast programs are an
emerging preventative service that may not be available in all areas, educating PCPs about these
guidelines will better prepare them to assess risk and share in further decision making with their
patients for the future (Cadiz et al., 2013).
Problem Statement
Risk of undiagnosed breast cancer among women and men between the ages of 30-50
years who have a greater than average risk for breast cancer, is indicated by breast cancer
diagnoses among this population and partially-results from a delay in screening due to lack of
provider knowledge about the need for early screening. The goal of this project was to create,
distribute and evaluate a relevant eLearning module that educates the primary care provider
regarding specialized care of the high-risk population, and to affect a behavior change among
PCPs to recognize their role in the preventative care of high-risk patients.
Gap Analysis
This project focused on one community, Snohomish County, in Western Washington,
approximately 20 miles north of Seattle. One diagnostic breast center located in Everett,
Washington, and serves patients in this community from two main medical groups, Providence
Medical Group and The Everett Clinic, as well as two small practices, Seamar Medical Group
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and Community Health Centers. The breast center completes about 12,000 screening
mammograms per year, and 12-15,000 diagnostic exams and procedures for patients including
those referred in from other screening sites in the community. The breast center also employs
advanced practice nurses who are trained in providing evidence-based care for patients at highrisk for breast cancer. In 2014, the high-risk breast program launched, but referrals where less
than 100 patients the first year, although they have steadily increasing over time. In the first eight
months of 2017, nearly 500 patients had been seen in the high-risk program. Approximately
20% of these patients were referred by their PCP or obstetrician/ gynecologist who had previous
knowledge of the program and the service it provides, while the other 80% were identified as
potentially high-risk by the breast center staff during routine mammograms.
Many of the patients referred to the high-risk program are identified at the breast center
as potentially high-risk at the time of a routine mammogram. Their brief health history is
obtained and evaluated by the technologists and radiologists who perform and read the imaging
exams mammograms. The patient information is entered into the computerized mammography
system which estimates a lifetime risk factor using the Tyrer-Cuzick and NCI lifetime risk
models. Once the risk has been calculated, the primary care providers are notified of the findings
in the mammography report. For those patients estimated to have a lifetime risk greater than
20%, recommendations are made (in the mammography report), by the radiologist to the PCP, to
refer the patient for a comprehensive risk assessment with the high-risk program providers. The
onus of this referral is placed back with the PCP to generate, as well as to share in the decisionmaking with the patient about pursuing this care, as the radiologists do not manage on-going
patient care. The problem continues to be that many PCPs do not look for the recommendations,
nor do they have knowledge regarding high-risk and what a high-risk program offers in
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managing breast cancer prevention.
Review of the Literature
A search for literature related to the education of primary care providers about high-risk
breast programs was conducted using the search engines CINAHL, PUBMED, The Cochrane
Database and OVID. Terms including “high-risk”, “breast cancer”, “internet-based learning”,
“primary care providers”, “health care providers”, “continuing education”, “eLearning” and
“modules” were used. Articles were considered if they were peer reviewed and published
between 2007 and present. The initial combined search for articles found 174 articles. Articles
were used as supporting evidence for this project if they identified high-risk breast programs as a
resource for patients and providers, as well as those identifying a need for more of this
knowledge in our community. Articles were also included regarding the discussion of internetbased learning among health care professionals, including the development and evaluation of this
type of learning. Literature was excluded if the article could not be easily retrieved related to
cost or availability, was not peer-reviewed, did not include research pertaining to the holistic care
of high-risk patients and/or programs (i.e. articles specific to cancer care or genetics only), or
those that did not address the provider’s learning experience with at least part of the experience
using an electronic format.
Most of the information around high-risk breast care focused on the best imaging
modalities for the detection of breast cancer, genetic involvement in breast cancer, and cancer
care. Although these topics are central themes in the care of high-risk patients, only six articles
identified high-risk programs and the need for specialty care for high-risk patients. Evidence was
found to support the idea that patients at high-risk benefit from a program that includes a
comprehensive risk assessment, annual mammography and magnetic resonance imaging (MRI),
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yearly office visits and clinical breast exam with a qualified provider, and genetic testing (if
indicated) (Cadiz et al., 2013). Lifestyle modification education-including (but not limited to)
diet/ exercise programs, stress-reduction methods, and smoking cessation plans-is also an
important component of a high-risk program (Afonso, 2009).
The benefit of high-risk programs does not appear to be widespread among primary care
providers because literature supported that it was only after a cancer diagnosis was made that the
patients were found to have genetic mutations and/or strong family histories of breast cancer,
indicating provider education about identifying high-risk patients is currently subpar (Vanstone
et al., 2012). The USPSTF (2013) established guidelines for the primary care provider to
appropriately screen and refer patients found to have a family history of breast, ovarian, tubal
and peritoneal cancers for high-risk counselling; however, Quillin et al. (2013) found that only
one in 22 patients who had such family histories was appropriately screened and referred by their
PCP. Another study identified that primary care providers have an interest in identifying and
treating patients with risk, however they hesitate related to lack of knowledge (Gabram et al.,
2009). Kne et al. (2017) identified that the three contributing factors limiting the use of high-risk
services include identification by the provider of high-risk patients, appropriate referrals to
services for patients at high-risk, and follow through by the patient. Brafford and Bush (2016)
identified that the main reason for lack of compliance by the patient with high-risk care is the
expense related to advanced imaging.
The evidence is overwhelming that the PCPs must improve screening to capture and refer
these patients. It is expected that the patients will more readily follow the advice of their PCP if
they engage in shared decision-making about a referral. Once the patient has been identified and
mutual agreement between the PCP and the patient is made about a referral to a high-risk
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program, the high-risk team is in the unique position to take the burden of high-risk care from the
PCPs and instead work in collaboration to meet the preventative care needs of the patient (Cadiz
et al., 2013).
Primary care providers in Snohomish County typically have twenty-minute appointments
with each patient. It is difficult for the provider to gather all the necessary information about
breast cancer risk in that time period, especially when patients present for other pressing health
concerns. Additionally, patients are not always prepared to answer detailed questions about
family history during a short primary care visit. Several websites offer education, guidance or
tools to use in the care for the patients at high-risk. Many screening tools have been developed
for use during the PCP visit with the patient, but no specific tool has proven to be an
overwhelming favorite (Quillin et al., 2013). The Providence Health Systems Breast Cancer
Clinical Practice Guidelines committee has created a tool (Appendix A), however it is not known
to be widely used. To improve compliance with the use of screening tools in the primary care
setting, education about high-risk, as well as information about local programs, must be
delivered to the PCP to assist in the care of these patients.
The review of literature search regarding high-risk breast programs produced no data
regarding educational programs aimed at educating the health care provider or otherwise. Five
articles about the education of health care providers using eLearning programs were considered
for this project, as they offered insight into developing a module about high-risk programs based
on the experience of the authors in other areas of health care. These articles discussed the format
in which the authors used, as well as the tools they used to develop and evaluate their content.
The experience of these authors (discussed below) was considered in developing this project.
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A variety of educational platforms were used among different authors in creating learning
opportunities for health care providers. In each article reviewed, it did not appear that a common
framework, specific to the learner population, was chosen, however each article reviewed
appeared to have a holistic approach to their content design. Each article discussed knowledge
of the provider regarding the topic, but also included information about communication and
behavior of health care profession in delivering care to the patient.
One article described a study that used the Medscape Educational Platform (Buriak &
Potter, 2013) to deliver an education module regarding cancer survivorship planning to
multidisciplinary professionals including registered nurses, nurse practitioners and physicians.
This type of study had high participation because it was open to various providers. Another
project that yielded good results used the American Association of Nurse Practitioners
Continuing Education (AANP-CE) platform to educate nurse practitioners about culturally
sensitive care concerning cervical cancer disparities among American Indian women (Peltier,
2015). Delf (2012) described a process for educating non-medical personnel about bone scans
using an independent virtual learning platform with software to build and deliver the program,
which also showed promising results.
Finally, two articles offered educational opportunities to health care professionals with
at least part of the experience completed in an on-line format. Bryant, Puri, Dix, and Ahmed
(2016) offered an in-person class for health care professionals, mainly midwives, about
delivering patient education regarding Down’s Syndrome. They used an on-line platform for
surveying their population at three different intervals following the provider education. Their
results also showed good evidence that learning and behavior change occurred. Gregg and
Twibell (2016) studied the effect of a program where graduate nursing students learned about
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stress management strategies offered through on-line coursework at Ball State University.
Following the class and some self-exploration of different methods, the participants were
surveyed at different intervals to assess the effects. The project included learning, practicing and
teaching components to allow for empathetic care of patients in the future by first discovering
one’s own ability to manage stress (Gregg & Twibell, 2016). Again, the results were positive.
It is important to consider the tools these authors used to design and evaluate their
programs for optimal learning. Two articles discussed the use of the ADDIE (analysis, design,
development, implementation and evaluation) instructional system model to develop their
content (Buriak & Potter, 2013; Delf, 2012). Buriak and Potter (2013) also included the use of
Mayer’s “Twelve evidence-based principles for multimedia-modality, interactivity and special
contiguity” and Gagne’s “Nine Events of Instruction” to provide guidance in the development of
an eLearning module while using anecdotal, case-based presentation of learning material. It
reached a wide variety of providers and concluded that this type of learning has the potential to
reach around the globe delivering education while collecting data from different areas of
practice. Peltier (2015) used the Knowles’ five principles of adult learning to develop the
presentation which was well received by nurse practitioners over a large geographic area in the
United States; however, because it was offered through the AANP-CE platform, it was limited to
nurse practitioners, and the few other disciplines who accessed the site for education materials.
It was concluded that this material would benefit all types of providers, and therefore, should be
shared through different platforms (Peltier, 2015).
Three of the articles reviewed used the Kirkpatrick Model (2016) to guide the design and
survey of the material, as it considers four elements of educational design which include
reaction, learning, behavior and results. Bryant, Puri, Dix, and Ahmed (2016) identified that
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using the Kirkpatrick Model includes the identification of the learning objectives from an
organizational perspective. This is especially important because those who work with the
implementation of evidence into practice are the experts, who by default, recognize the lack of
knowledge among a community. Gregg and Twibell (2016) further added to this by including the
most recent expansion to the Kirkpatrick Model which considers learner engagement and
perceived relevance under the first element of reaction. Engagement and relevance of
educational material are important factors to consider in changing behavior. Delf (2012)
identified that eLearning proved to be effective at renewing interest and insight into practice,
thus changing behavior, which is the third element of the Kirkpatrick Model. Addressing the four
elements of the Kirkpatrick Model in the development and analysis of eLearning appears to be
an effective and useful tool that is often preferred especially in this type of learning environment.
When developing an eLearning module for educating PCPs about high-risk breast
programs, it is important to use a platform that is accessible to all providers including physicians,
nurse practitioners and physician’s assistants in one community. Limiting this to one discipline
will not achieve the desired outcome to educate and evaluate learning of all PCPs around this
topic. Evidence indicates that this type of education is needed in health care today, especially for
all PCPs who are key stakeholders in identifying patients at high-risk. It is also important to
include guidelines or development methodology to ensure that content, objectives, and questions
are created with the learner population in mind. Using the Kirkpatrick Model allows for
consideration of important elements of educational design to create effective learning
opportunities for health care providers.
Evidence Based Practice: Verification of Chosen Option
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The evidence-based practice guidelines that were reviewed and chosen for this project are
those defined by the NCCN (2017) (Appendix B) for women with a greater than twenty percent
lifetime risk of developing breast cancer. The NCCN is comprised of world-renowned scientists
and researchers who collaborate and review the latest evidence. When creating and updating
their recommendations, professionals gather from institutions around the globe to participate in
an on-going and iterative process to set guidelines for clinicians to follow regarding cancer and
risk. The NCCN follows the same grading system as many other organizations setting guidelines
based on clinical research and scientific evidence. For the care of women at high-risk for breast
cancer, their grade of the evidence is 2A: Based on lower-level evidence, the consensus of the
NCCN team deems the interventions as appropriate (NCCN, 2017). Recommendations in
accordance with these guidelines include the following: 1. A clinical encounter every six to
twelve months to begin at the age identified as being at higher risk, 2. Referral to a genetic
professional if not already done, 3. Annual screening mammogram (preferably with
tomosynthesis), 4. Annual breast MRI, 5. Consideration of risk reducing strategies, and 6. Selfbreast awareness enabling patients to promptly report any changes (NCCN, 2017).
Understanding that patients referred for high-risk care may incur the emotional stress and
costs of increased screening (depending on insurance and coverage benefits), education to the
provider will emphasize that prevention and early detection of breast cancer is proving to be
beneficial for the high-risk group. One systematic review showed that MRI alone increased
sensitivity in detecting breast cancer, however centers employing strategies that include MRI,
mammography, and clinical breast exam have shown sensitivity of 93-100% (Lord et al., 2007).
A recent meta-analysis concluded that when screening patients of all ages with a strong familial
history of breast cancer with both MRI and mammography, sensitivity increased to 98% (from
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55% sensitivity with mammography alone); however, this may lead to decreased specificity and
may increase false positives and over diagnosis (Phi et al., 2017).
As evidenced by the literature, it is especially important for PCPs to know how to
identify and refer patients who fall into the higher risk category to prevent over diagnosis. This
is the very reason screening recommendations exist for women at average risk, but also why
there is so much controversy and disagreement among groups about screening for average risk.
Experts agree that risk-based, individualized screening is important to reduce the burden of over
diagnosis and diminish the morbidity of treatment (Monticciolo, Helvie, & Henrick, 2017). In
other words, it is crucial that PCPs and patients understand risk and how to best screen patients
based on their risk. The NCCN has created guidelines for high-risk patients because they benefit
from additional screening efforts to prevent or catch cancer at an early stage. Sharing this
information through a learning module will prepare the PCP to identify and refer patients who
qualify for this care.
Theoretical Framework/Evidence Based Practice Model
The Theory of Diffusion of Innovation was developed by Everett Rogers (2003) and
describes the process by which to diffuse new knowledge to a social group. It considers aspects
of how to diffuse technology, or innovation, among groups. Because the concept of high-risk
breast programs is a fairly new one, an educational module was created for this project to assist
providers in identifying patients at high-risk, and to help understand the recommendations and
health management for these patients. Rogers’ theory suggests that one key aspect of diffusing
innovation is by forming early adopters to help spread new information among a population
(Rogers, 2003). Additionally, the theory discusses stages by which innovation is diffused among
groups (Appendix C). These steps include dissemination, adoption, implementation and
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maintenance. It is important to consider that educational modules must address key components
of learning so that the learners will engage in the information and spread it amongst their social
group. Once full understanding about risk and appropriate care for those at high-risk becomes
well recognized among providers and patients alike, the information will have successfully
diffused among the population.
Methods
To provide a meaningful learning opportunity for the providers in the community about
high-risk breast programs, this quality improvement project included the development of an
internet-based education module that was delivered to PCPs of adult patients (including family
practice and internal medicine). The learning module was developed using the NCCN guidelines
for high-risk individuals (National Comprehensive Cancer Network, 2017). Early adopters of
this innovation were identified as three physician leadership champions and one clinic manager
champion. One champion was located at each of the four sites who communicated with and
encouraged PCPs to participate and learn this content in order to promote and support best
practice.
Goals and Objectives
The goal of this project was to educate primary care providers about high-risk breast
programs and how high-risk specialty care may serve as an adjunct in preventative care in
collaboration with the PCP. Understandably, PCPs have a number of priorities during an office
visit. Breast health is one of many items assessed during the routine health physical.
Acknowledging this is necessary to gain the support of the PCP.
The objectives for this project were developed considering the four elements of
educational design including reaction, learning, behavior and results (Kirkpatrick, 2016). The
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objectives were: 1. Present information that is relevant and engaging to capture buy-in from
PCPs, 2. Educate PCPs with evidence-based recommendations to give them the knowledge to
engage in shared decision-making with their patients, and 3. Influencing the PCP’s behavior to
appropriately refer patients to experts who will then reduce the burden of high-risk breast care on
their practice. The true organizational benefits from the accomplishment of these three
objectives will be seen moving forward, as the time limits on this project cannot fully capture the
extent of impact.
Survey Design
The Kirkpatrick model has previously been used for more than 50 years for survey
design, many in health care settings, to evaluate goals and objectives, generating evidence
beyond the learners’ behaviors and attitudes (Leslie et al., 2013). Addressing reaction, an
essential component of evaluation, gives the researcher insight and feedback regarding the
participants attitude toward the learning modality; however, positive feedback does not
necessarily indicate that learning has occurred (Rouse, 2011).
The second level of evaluation addresses whether learning has occurred. Learning is
often determined best when a pretest and posttest are analyzed using a statistical test, such as the
t-test; however, the acquisition of knowledge does not indicate that the behavior of the
participant will change (Rouse, 2011). Analysis of behavioral changes is the third level of
evaluation using the Kirkpatrick Model. The extent to which a participant applies their new
knowledge and changes their behavior is key in successful project design (Bryant, Puri, Dix, &
Ahmed, 2016). Results can be measured only after the first three levels of learning have been
addressed and adequate time has passed to observe results.
.
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Project Site and Population
The project took place in Snohomish County, Washington. The county has nearly
780,000 residents, making it the third largest county in Washington with a predominantly
Caucasian population (80%), but also including Hispanics (9%), Asians (10%), AfricanAmericans (3%) and Native Americans (1.5%) (Vance-Sherman, 2015). Four large practices
were chosen based on their practice locations (with more than two satellite clinics serving
different areas of the county) and practice size (had at least 10 qualified providers.) A total of
103 providers were identified as eligible with one practice having 21 PCPs who were either
internists or family practice providers, the second having 35 providers, the third having 34
providers, and the fourth having 13 providers.
Ethics and Human Subjects Protection
This eLearning project was reviewed by the University of Massachusetts Amherst
Institutional Review Board and certified as exempt on January 17, 2018 (Appendix G). The
project did not involve contact with any patients. Providers were contacted for participation via
champions within their own organizations to allow for complete anonymity. The DNP student
was not notified of the names of participants by the champions. The DNP student emailed a link
to the champions who disseminated the link to the primary care providers of adult patients. The
link connected the participant directly to the module for anonymous completion. No identifying
information was collected from the participants. All the results were collected by the Microsoft
Mix platform in aggregate form.
Results
The link to the eLearning module entitled “Identifying and Managing Patients at Highrisk for Breast Cancer”, with a pretest and posttest integrated into the format, was sent out to 103
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PCPs in Snohomish county over a 30-day period. Twenty-three (22.3%) participants completed
the pretest, module and posttest. There were no partially completed pretests or posttests, but
there was a total of 33 views, indicating that the module was viewed but not completed by ten
participants. The follow-up survey link was sent out to the same group of participants via the
clinic champions after the module closed. It remained open for 30 days with a total of ten
participants completing the survey.
The participants included advanced practice nurses (47%; n = 11), physicians (39.1%; n =
9) and physician’s assistants (13.0%; n = 3). The years of service for the participants was evenly
distributed with 21.7% (n = 5) having practiced ten or more years, 26.1% (n = 6) having
practiced 5-10 years, 26.1% (n = 6) having practiced 2-5 years, and 26.1% (n = 6) having
practiced less than two years.
Development of the learning module occurred between November and December 2017.
The Microsoft Mix Platform was used to create the eLearning module because it is user friendly,
allowed for anonymity, and allowed for easy integration of the pretest and posttest, as well as
data collection. Content slides (Appendix D) based on the objectives were created specifically
for this module. The module introduced the topic and information regarding implied consent,
then proceeded to an integrated pretest, followed by 17 slides with learning content, then
concluded with a posttest and evaluation. The module was narrated but gave the participants the
ability to proceed through slides at their own pace. The entire length of the narrated module was
six minutes, however the participants had the ability to move forward and backward as needed to
review each slide. In being mindful of limited time the PCPs may have to complete this module,
the intent was that the participants spend the time they needed to complete the module, but not
take more than an estimated 20 minutes.
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Repeated measures surveys using a Likert Scale were presented to the PCP participants
using questions that related to reaction, learning, behavior and results, as well as questions
regarding demographics and current practices (Table 1).
Table 1. Survey questions and relationship to Kirkpatrick model
Model Level
1. Reaction

2. Learning

3. Behavior

4. Results

Questions
This training format was beneficial to my
schedule.
This training is important for primary care
providers.

Measure
Five-point
Likert-type
categorical
scale (strongly
agree to
strongly
disagree)

Survey

I use a screening tool to identify risk.
I understand current recommendations for
high-risk patients.
I educate my patients regarding risk for
breast cancer.

Five-point
Likert-type
categorical
scale (strongly
agree to
strongly
disagree)

1, 2

I refer patients to experts for high-risk care.
I engage my patients in shared decisionmaking.
I collaborate with experts regarding highrisk care.

Five-point
Likert-type
categorical
scale (strongly
agree to
strongly
disagree)

1, 2

Since training, I more often refer patients
for risk assessment.
Since training, my collaboration with
experts has increased.
This training has helped reduce burden on
my practice.

Five-point
Likert-type
categorical
scale (strongly
agree to
strongly
disagree)

2
2

1, 2
1, 2

1
1

3
3
3

There was a pretest (n = 23) before engaging in the learning section, a posttest (n = 23) and an
evaluation immediately following the learning section. It was accessible between February 1,
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2018, and March 1, 2018. A short follow-up survey (n = 10), to assess results related to
behavioral change and patient care impact, was then conducted in the month following the initial
learning module. It was available March 1, 2018, through March 30, 2018, following the closure
of the initial module. The third survey did not take more than five minutes to complete. Many
of the questions in these surveys addressed the four levels of evaluation: reaction, learning,
behavior and results, based on goals and objectives created by the DNP student and experts in
the in high-risk breast care within the community. Participants were asked about when they
discuss breast cancer risk with their patients. The majority, 65.2% (n = 15), answered that they
address risk during routine physical exams, while 26.1% (n = 6) answered that they only discuss
risk if the patient initiates it, and 8.7% (n = 2) answered that they only discuss risk when there is
a breast issue. None of the participants denied ever discussing risk with their patients. The
participants were also asked about which resources they use to assess patients for risk, with
65.2% (n = 15) using the United States Preventative Services Task Force (USPSTF), 21.7% (n =
5) using the American Cancer Society, and 13.0% (n = 3) not using any resources. None of the
participants use the National Comprehensive Cancer Network (NCCN) guidelines to guide risk
assessment.
The reaction to the teaching module was overall positive. Table 2 summarizes the results
from the questions regarding the participants reaction to the module. Questions assessed the
participants beliefs about the material and the format in which the material was presented. A
Likert scale was used to rate answers as: Strongly agree (5), Agree (4), Neutral (3), Disagree (2),
and Strongly disagree (1).
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Table 2. Reaction to module
(n = 23)

Strongly
agree
n (%)

Agree
n (%)

Neutral
n (%)

10 (43)

11 (47.8)

2 (8.7)

0

0

Risk training is important for PCPs

11 (52.2)

11 (52.2)

0

0

0

Material presented is relevant to my
practice.

10 (43.5)

10 (43.5)

3 (13)

0

0

This learning improves the care I
deliver.

4 (17.4)

15 (65.2)

3 (13)

1 (4.3)

0

This learning promotes collaboration
among providers of care.

1 (4.3)

15 (65.2)

7 (30.4)

0

0

This learning enhances my awareness
of resources in our community.

0

13 (56.5)

7 (30.4)

2 (8.7)

1 (4.3)

Questions
This training is beneficial to my
schedule

Strongly
Disagree disagree
n (%)
n (%)

Although corresponding value for each answer was not needed for statistical analysis in this
section, it was used for questions in upcoming sections. Each question collectively scored over
50% in the “Strongly agree” and “Agree” categories of the Likert Scale.
Repeated measure survey questions addressed the learning and behavioral components of
the module. To evaluate the statistical significance of learning and impact on behavior the
participant gained from this module, a comparison of pretest and posttest answers in these areas
were analyzed using a paired sample t-test with an alpha set at .05 to assess the null hypothesis
that the 5-point Likert scale rating on the pretest is equal to 5-point Likert scale rating on the
posttest. Table 3 lists the topics of questions regarding knowledge and behavior, then gives the
number of participant answers and percentage for each question from the pretest and posttest,
and the paired t-test analysis of each category.
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Table 3. Knowledge and behavior repeated measure analysis (n = 23)
Pretest Posttest
Std.
n, (%)
n, (%)
Mean
Dev.
t
Knowledge
Understand recommendations
-0.8696 1.14035 -3.657
5-Strongly agree
2 (8.7)
5 (21.7)
4-Agree
3 (13.0) 14 (60.9)
3-Neutral
12 (52.2) 4 (17.4)
2-Disagree
6 (26.1)
0
1-Strongly disagree
0
0
Educate patients about risk
-0.2174 1.1264 -0.926
5-Strongly agree
2 (8.7)
4 (17.4)
4-Agree
15 (65.2) 14 (60.9)
3-Neutral
3 (13.0) 4 (17.4)
2-Disagree
3 (13.0)
1 (4.3)
1-Strongly disagree
0
0
Behavior
Use of a screening tool
-1.4783 0.73048 -9.71
5-Strongly agree
0
0
4-Agree
1 (4.3%) 15 (65.2)
3-Neutral
4 (17.4) 8 (34.8)
2-Disagree
16 (69.5)
0
1-Strongly disagree
2 (8.7)
0
Likelihood to refer for risk assessment
-1.3913 1.37309 -4.859
5-Strongly agree
2 (8.7)
4 (17.4)
4-Agree
0
14 (60.9)
3-Neutral
5 (2107) 3 (13.0)
2-Disagree
16 (69.7) 2 (8.7)
1-Strongly disagree
0
0
Paired sample t-test with alpha set at .05

df

sig.

22

0.001

22

0.365

22

0.000

22

0.000

Two questions evaluated whether knowledge had been acquired after participating in the
learning module. The question asked the participants about understanding current
recommendations for assessment of high-risk patients found there was a statistically significant
difference, thereby rejecting the null hypothesis that learning would not be a significant
difference between the pretest and posttest. For the question regarding the education of patients
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by the participant regarding high-risk, there was not a statistical difference between the pretest
and posttest, thereby failing to reject the null hypothesis.
Two questions were used to evaluate the behavior of the participants, rather the
confidence that the participant had that the learning would influence their behavior. The first
question was regarding the use of a screening tool in the practice setting, and the second question
asked about the likelihood that the participant would appropriately refer for risk assessment.
There was a statistically significant change from the pretest to the posttest, allowing the rejection
of the null hypothesis that behavior change would not occur.
The participation in the follow-up survey was low (n = 10), but the results appear to be
positive. The questions below (table 4) assessed whether the participants had sustained
behavioral changes related to their learning.
Strongly
agree

Agree

0

6 (60.0)

3 (30.0)

1 (10.0)

0

I am now using an assessment tool to
screen my patients for breast cancer
risk.

0

3 (30.0)

4 (40.0)

2 (20.0)

1 (10.0)

I know what specialized resources are
available to reduce the burden of highrisk breast care on my practice.

3 (30.0)

5 (50.0)

2 (20.0)

0

0

0

3 (30.0)

5 (50.0)

1 (10.0)

1 (10.0)

Table 4. Results follow-up survey
Questions
I more often consider individualized
breast cancer risk for my patients.

My collaboration with experts/peers
regarding patients at high-risk for
breast cancer has increased.

Strongly
Neutral Disagree disagree

The results of the follow-up survey after one month indicate that PCPs are more likely to
consider individualized risk for their patients (60% favorable), and have knowledge about how to
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reduce the burden of high risk breast care on their practice (80% favorable). The use of a
screening tool, as well as collaboration with experts about high risk care remained neutral.
Discussion
This project provided an eLearning module to providers to help them understand the
current recommendations regarding the patient at high-risk for breast cancer. The objectives for
this project were met through the presentation of information that was relevant and engaging to
capture buy-in from PCPs. Primary care providers were educated about evidence-based
recommendations to enable them to engage in shared decision-making with patients about high
risk. Additionally, PCP’s behavior was influenced to appropriately refer patients to experts who
reduce the burden of high-risk breast care on their practice. The participating PCPs, 22.3% of
the identified population, were surveyed with a pretest and posttest built into an eLearning
module. An additional follow-up survey was sent out 30 days after the initial module, of which
9.7% participated.
The reaction to the module from participants was positive. Questions regarding reaction
to the eLearning module were answered with the majority stating that the format was beneficial
to their schedule, the training was important and relevant to their practice setting, the training
improved care delivery, and that it enhanced resource awareness and collaboration.
Kirkpatrick (2016) states that positive reaction to learning is crucial in successful
learning, and eLearning appears to be a beneficial method of education for busy PCPs. Despite
the use of champions at each practice location, the participation by PCPs was not as high as
anticipated. The thought was that the ease in which the PCP population could access the
modules on their own would positively influence participation. The champions themselves were
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busy practice leaders and likely did not continually remind their PCPs to take the survey as often
as had hoped.
Rogers’ theory (2003) discusses that adoption of innovation is a key step in diffusing it
into a population, however it must be followed by implementation and maintenance, the third
and fourth characteristics of the diffusion of innovation process. While the champions were
considered the early adopters, the implementation process needs more support to get the
information out to a wider group of participants. It does appear that a representative sample of
PCPs participated proving that the education about high-risk breast care is lacking and needs to
be diffused overall.
Many of the questions help gain insight to the current practices of the PCPs in this
community, including the engagement in shared decision-making with their patients. The
module educated the PCPs about the NCCN guidelines, educating their patients routinely, and
offered guidance about using a tool and referring to specialists when needed. Not many PCPs in
this group were using a tool to help screen for high-risk patients, and none of the participants
were using the NCCN guidelines to help guide their treatment of patients. The lack of tool usage
may be directly related to lack of valid tool availability; however, it may also be a cumbersome
and time-consuming process. While some tools used in health care have been validated and are
used repeatedly, there has not been a standard tool developed for breast risk assessment. The
PCPs and patients are also bombarded with conflicting information about breast care from
different organizations, so it is often difficult to understand what should be done. The NCCN
guidelines (2017) offer clear and concise direction for the treatment of patients, however the
PCPs do not appear to consistently use these guidelines, as most appeared to follow the USPSTF
guidelines.
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The eLearning module did positively impact the PCPs ability to engage with their
patients. Significant improvements in both knowledge and confidence in behavioral changes
were observed. This population now understands that the NCCN guidelines are a concise
resource, are more likely to consider using a tool in their practice to screen for risk, and are more
likely to refer for assessment with an expert. Although the use of a tool and the willingness to
collaborate remained neutral in the follow-up survey, this survey only captured a small number
of participants. The analysis between the pretest and posttest indicated a very significant
improvement in willingness to use a screening tool and collaborate with an expert, however lack
of a valid tool and limited breast care experts in the community are likely contributing to the
neutrality of the follow-up survey answers. Additionally, greater than one month may be needed
to adequately assess the impact of the learning.
The education of patients by the PCP was the only area tested where significant
improvement was not observed following the learning. This was an interesting finding because
risk for breast cancer is not adequately addressed in the primary care setting according to the
participants. While the majority of this population screen for risk during the annual exam,
approximately 35% do not address it yearly. Breast cancer risk potentially changes yearly for
patients related to health changes, family history changes, and age.
Risk should be addressed yearly and patients must be aware of risk to ensure it is
included in their routine care. This must be an area of education that the PCP covers while
assessing for other risks, although anecdotal evidence from patients suggests that discussion
regarding the initiation of mammography is as far as the conversation goes between the patient
and PCP in many instances. This may be related to the numerous health topics that patients
address with their providers in the limited time available during routine exams, however it
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remains important for the provider to consider the patient’s personal and family history.
Individualized risk assessment is necessary for thorough preventative care, and this appears to be
a current deficit in primary care.
Limitations
The main limitation with this project was the lack of participation from providers.
Education of the PCP regarding high-risk breast care was found to be valued, however the
overall participation was expected to be higher, especially because each site had a champion to
help spread the value of this education. For future efforts in educating PCPs, incorporating more
of an incentive should be used to entice more participation. Continuing education credits
combined with longer module availability may improve participation. It may also be helpful to
understand if providers are currently bombarded with learning modules on various topics despite
their convenience.
Changing the delivery of the education may be beneficial as well. Although eLearning
modules are often well-received related to their ease in access, in-person delivery of breast
cancer risk education may be beneficial in capturing an audience, as well as answering questions.
Given the length of the eLearning module, this information may be easily translated into a
classroom format, thereby allowing brief teaching lessons during staff meetings or group
learning opportunities.
The comments made by a handful of participants at the final question of the evaluation
included a few common themes. Participants wanted a valid risk assessment tool to allow for
ease in screening. They also requested contact information for programs providing breast risk
and genetic health assessments in our area, but this was not given related to the research process
and unbiased approach to educating providers. Perhaps providing a comprehensive list of all
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programs within a demographic area would be appropriate for future researchers. Two
participants indicated wanting an open forum to ask questions; this reinforced the idea that an inperson learning option would likely be beneficial.
Conclusion
Patients at high-risk for developing breast cancer should be evaluated more frequently to
prevent cancer, or at minimum, detect cancer in early stages. The USPSTF does not set
guidelines for mammography of patients who are at high-risk, yet many PCPs are following the
general guidelines for the average risk population. The NCCN (2016) has created evidencebased guidelines for the support and monitoring of patients who are found to be at high-risk,
however, this evidence continues to be slowly disseminated.
This project aimed to educate primary care providers in one community about the science
and value in high-risk breast programs. Through the use of an eLearning module, PCPs gained
understanding about to how best manage this patient population while ensuring preventative care
guidelines through collaboration with experts. Additionally, this education has shown significant
improvements in knowledge and confidence in future behaviors, thereby empowering the PCP to
engage patients in shared decision-making around preventative care for patients with high-risk
for breast cancer.
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Appendix A. Providence Health System Breast Cancer Risk Screening Tool

Breast Cancer Risk Screening Tool (Providence Health System, 2016)
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Appendix B. National Comprehensive Cancer Network Guidelines: Breast Cancer
Screening and Diagnoses Version 1.2017

Women who have a lifetime risk >20% as defined by models that are largely dependent on
family history:
•

•

•

•
•

Clinical encounter every 6-12 months
o To begin when identified as being at high-risk
o Referral to genetic counseling if not already done
Annual screening mammogram
o To begin 10 years prior to the youngest family member but not less than age 30
years
o Consider tomosynthesis
Recommend annual breast MRI
o To begin 10 years prior to the youngest family member but not less than age 25
years
Consider risk reduction strategies
Breast awareness

Breast Cancer Screening and Diagnoses Version 1.2017 (NCCN, 2017)
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Appendix C. Roger’s Theory Components
The Innovation-Decision Process (Dingfelder & Mandell, 2010)

Dissemination

Adoption

Implementation

Maintenance

Strategies to make
potential adopters aware
of innovation

Commitment to begin
using innovation
(consider 5 variable)

Putting innovation to use

Degree to which
innovation is used over
time.

PERCEIVED CHARACTERISTICS OF THE INNOVATION:
1.
2.
3.
4.
5.

Relative Advantage
Compatibility
Complexity
Trialability
Observability
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Appendix D. eLearning Module Slides and Follow-up Survey Outlines

 MODULE 1.

Identifying & Managing Patients at High Risk for Breast Cancer
An eLearning Module for Primary Care Providers
Introduction & Purpose
WHAT: Brief eLearning module for PCPs (this is approximately 20 minutes in length.)
WHY: To gather info about current practices and inform PCPs about evidence-based guidelines.
WHO: All PCPS in Snohomish County willing to participate.
WHEN: Available for 30 days. A brief follow-up survey will be sent via email approximately
one month following this initial survey.
WHERE: You’re here!
THANK YOU FOR PARTICIPATING!!!

IMPLIED CONSENT
You are being invited to participate in a research study titled Identifying and Managing Patients
at High Risk for Breast Cancer. This study is being done by Erin Chaney, BSN, RN, DNP
student, from the University of Massachusetts Amherst. You were selected to participate in this
study because you are a primary care provider in Snohomish County, WA.
The purpose of this research study is understand the current practices of primary care
providers around the screening of patients at high risk for breast cancer, as well as to give
education to primary care providers about the management of these patients in accordance
with evidence-based guidelines. If you agree to take part in this study, you will be asked to
complete an online survey/questionnaire. This survey/questionnaire will ask about current
practices, personal knowledge about the topic, beliefs and actions you have about the care of
this population, and the reaction you have to this type of learning. It will take you
approximately 20 minutes to complete. Approximately 30 days following this module, you will
receive a link to a short follow-up survey via email. This survey will take less than 5 minutes to
complete.
You may not directly benefit from this research; however, we hope that your participation in the
study may will lead to the development of better screening practices and collaborative
management of patients at high risk.
We believe there are no known risks associated with this research study; however, as with any
online related activity the risk of a breach of confidentiality is always possible. To the best of
our ability your answers in this study will remain confidential. We have minimized any risks by
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having your leadership distribute this module link to providers through email distribution lists
and not including any questions that will lead to your identification. Additionally, you have
accessed this module within a cloud-based platform that does not record any information
except your answers to the survey questions.
Your participation in this study is completely voluntary. By continuing with this module, you are
consenting to participate.
If you have questions about this project or if you have a research-related problem, you may
contact the researcher, Erin Chaney, echaney@umass.edu, 425-346-5982, or, faculty advisor,
Dr. Rachel Walker, PhD, RN, r.walker@umass.edu, 413-545-0250. If you have any questions
concerning your rights as a research subject, you may contact the University of Massachusetts
Amherst Human Research Protection Office (HRPO) at (413) 545-3428 or
humansubjects@ora.umass.edu.
Thank you for your participation in this research.
PRETEST
CONTENT
WHEN TO START MAMMOGRAPHY?
AVERAGE RISK
USPSTF- Biennially at 50 years
ACS- Annually at 45 years
ACR- Annually at 40 years
ACOG- Annually at 40 years
HIGH RISK
USPSTF- May benefit from increase imaging
ACS- Annual mammography and MRI
ACR- Annual mammography and MRI
ACOG- Annual mammography and MRI
CONSIDERATIONS for DETERMINING RISK
Personal History
History of breast or ovarian cancer
Age
Chest wall radiation
Dense breast tissue
History of breast biopsy (for any reason)
Ashkenazi-Jewish Decent
Lifestyle
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CONSIDERATIONS for DETERMINING RISK
Family History
Breast or ovarian cancer in any 1st or 2nd degree relative
Age of family member at cancer diagnosis
Known male breast cancer
Limited family information (i.e. adoption) or limited female relatives
Ashkenazi-Jewish Decent
CONSIDERATIONS for DETERMINING RISK
Genetic Mutations
Known or suspected BRCA1/ BRCA2 mutation
Other known or suspected genetic mutations including: ATM, CHD1, CHEK2,
NBN, NF1, PALB2, PTEN, STK11, TP53 (p53)
PCPs Role
Breast Cancer Risk Screening Tool (Providence Health System, 2016)
Consider USING a tool
Considering Breast Density
Breast Density Levels
PATIENT EXPERIENCE WHEN REFFERED TO HIGH RISK PROGRAM
MODELS USED TO CALCULATE RISK
Meet with a breast care provider
Risk factors considered and software used to calculate lifetime risk
Greater than 20% lifetime risk is HIGH RISK
Annual Imaging/monitoring and lifestyle modification education provided
Genetic testing provided as indicated
Referrals to surgeon (prophylactic surgery) and oncology (chemo prevention) as indicated
Collaborative Care: DECREASING THE BURDEN OF CARE FOR PCPs
COST OF CARE
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CASE STUDY
42-year-old, Caucasian female (no Jewish ancestry) visits her primary care for annual health
check. She mentions that her 72-year-old mother has recently been diagnosed with recurrent
breast cancer with metastases following a two-year remission. No other breast or ovarian cancers
in maternal family known, but one maternal uncle died from throat cancer, and her maternal
grandfather died from lung cancer with brain metastases.
Her paternal great-grandmother had breast cancer at age 55 years. Her paternal grandmother died
of cancer at the age of 75 years, but the type of cancer was unknown (large abdominal tumors
found just prior to death in 1993.) Her father has had basal cell carcinoma removed from his face
in the past year. Neither the patient’s father or grandmother had any female siblings.
The patient has two young daughters with no other pregnancies. Prior to having children, she
took oral contraceptives for 10 years. She had a breast biopsy at age 18 years, which was a
benign fibroadenoma. No other health problems. BMI is 38.
Two years prior, she decided to have a mammogram despite her previous PCP telling her that she
probably didn’t need to start screening mammography until age 50 years. She was found to have
heterogeneously dense breast tissue.
WOULD YOU REFER THIS PATIENT FOR RISK ASSESSMENT?
Case Study Continued…
Risk assessment was discussed with the mammography technologist during her screening
mammogram. Because patient has sisters and daughters, she felt it was appropriate to follow-up
with a risk assessment. Additionally, she doubted that she was of average risk.
After giving a thorough history to the nurse practitioner at the High-Risk Clinic, she was found
to have a lifetime risk of 38%. She then discussed this finding with her mother who confirmed
that she had undergone genetic testing (following her second breast cancer diagnosis) and was
found to not have any mutations. The patient then contacted the High-Risk provider and gave
this information. The risk was recalculated and fell to 28%.
The patient was informed that genetic testing would be appropriate given her father’s family
history, however she decided to first ensure her life insurance policies were in order prior to
testing.
Although she has been determined to be at high risk for breast cancer, she will not need to start
annual MRIs until age 45 years per NCCN guidelines. She will, however, continue to be
followed in the high-risk program with annual mammography, plus lifestyle modification
including weight loss and exercise.
THANK YOU
YOUR PARTICIPATION IS GREATLY APPRECIATED
PLEASE PROCEED TO THE POSTTEST AND EVALUATION
POSTTEST
In 30-60 days…
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…You will receive another email link to a very short survey regarding this module, in an effort to
assess whether this education impacted your practice.
Your participation in the short follow-up will be greatly appreciated to complete this project.
Thanks again!
EVALUATION
You are finished!

 MODULE 2. Identifying & Managing Patients at High Risk for Breast Cancer
Follow-up survey
IMPLIED CONSENT
You were being invited to participate in a research study titled Identifying and Managing
Patients at High Risk for Breast Cancer. This study is being done by Erin Chaney, BSN, RN,
DNP student, from the University of Massachusetts Amherst. You were selected to participate in
this study because you are a primary care provider in Snohomish County, WA.
The purpose of this research study is understanding the current practices of primary care
providers around the screening of patients at high risk for breast cancer, as well as to give
education to primary care providers about the management of these patients in accordance
with evidence-based guidelines. If you participated in the initial eLearning module (a link was
sent to you approximately 30 days ago) please complete this brief follow-up survey.
You may not directly benefit from this research; however, we hope that your participation in the
study may will lead to the development of better screening practices and collaborative
management of patients at high risk.
We believe there are no known risks associated with this research study; however, as with any
online related activity the risk of a breach of confidentiality is always possible. To the best of
our ability your answers in this study will remain confidential. We have minimized any risks by
having your leadership distribute this module link to providers through email distribution lists
and not including any questions that will lead to your identification. Additionally, you have
accessed this module within a cloud-based platform that does not record any information
except your answers to the survey questions.
Your participation in this study is completely voluntary. By continuing, you are consenting to
participate.
If you have questions about this project or if you have a research-related problem, you may
contact the researcher, Erin Chaney, echaney@umass.edu, 425-346-5982, or, faculty advisor,
Dr. Rachel Walker, PhD, RN, r.walker@umass.edu, 413-545-0250. If you have any questions
concerning your rights as a research subject, you may contact the University of Massachusetts
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Amherst Human Research Protection Office (HRPO) at (413) 545-3428 or
humansubjects@ora.umass.edu.
Thank you for your participation in this research.
Follow-up Questions
Considering the content of the eLearning module you reviewed within the past two months,
please answer the following questions…
THANK YOU
YOUR PARTICIPATION IS GREATLY APPRECIATED
AGGREGATE FINDINGS OF THIS RESEARCH WILL BE SENT TO YOUR
LEADERSHIP FOR DISTRIBUTION FOLLOWING ANALYSIS.
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Appendix E. Pretest and Posttest Questions
Question
How often do you discuss risk
regarding breast cancer with your
patients?

Type

Survey

Multiple choice:
a) During routine physical exam
b) Only when the patient asks
c) Only when there is a breast concern
d) I never discuss risk
Multiple Choice:
a) USPSTF Guidelines
b) ACS guidelines
c) Institutional guidelines
d) NCCN Guidelines
d) Other:_________________

1

Likert scale (strongly agree, somewhat
agree, neutral, disagree, strongly
disagree)
Likert scale (strongly agree, somewhat
agree, neutral, disagree, strongly
disagree)
LEARNING (Knowledge and Confidence)
I use a screening tool in my practice Likert scale (strongly agree, somewhat
to appropriately identify patients at agree, neutral, disagree, strongly
high-risk for breast cancer.
disagree)
I understand the most current
Likert scale (strongly agree, somewhat
recommendations used to determine agree, neutral, disagree, strongly
if patients are at high-risk for breast disagree)
cancer.
I appropriately educate my patients Likert scale (strongly agree, somewhat
regarding high-risk.
agree, neutral, disagree, strongly
disagree)
This training has increased my
Likert scale (strongly agree, somewhat
knowledge to educate my patients
agree, neutral, disagree, strongly
about high-risk.
disagree)
BEHAVIOR
I am confident that I refer patients
Likert scale (strongly agree, somewhat
for risk assessment appropriately.
agree, neutral, disagree, strongly
disagree)
This training has increased my
Likert scale (strongly agree, somewhat
confidence about referring patients
agree, neutral, disagree, strongly
for high-risk assessment.
disagree)
I routinely engage in shared
Likert scale (strongly agree, somewhat
decision making with my patients
agree, neutral, disagree, strongly
regarding breast cancer risk.
disagree)

2

What resources do you use to
determine breast cancer risk?

REACTION
This training was offered in a
format that is beneficial to my
schedule.
This training is important for
providers in primary care.

1

2

1, 2

1, 2

1

2

1

2

1, 2
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I often collaborate with experts
regarding breast cancer risk.
RESULTS (Institutional impact)
Since receiving training, I more
often refer patients for risk
assessment at the Breast Center.
Since receiving training, my
collaboration with experts/peers has
increased.
I believe that training has given me
resources to reduce the burden of
breast care on my practice.

Likert scale (strongly agree, somewhat
agree, neutral, disagree, strongly
disagree)

1, 2

Likert scale (strongly agree, somewhat
agree, neutral, disagree, strongly
disagree)
Likert scale (strongly agree, somewhat
agree, neutral, disagree, strongly
disagree)
Likert scale (strongly agree, somewhat
agree, neutral, disagree, strongly
disagree)

3

3
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Appendix F. Program Evaluation Questions
1. How many years have you been a healthcare provider?
Less than 1 years
2-5 years
5+ years
Greater than 10 years
2. What type of provider are you?
Physician
Advanced practice nurse (ARNP, FNP, AGNP, etc.)
Physician’s assistant
Other: ___________________
3. Using the following scale, please rate (check the appropriate box) the following statements to
best fit your evaluation of this educational offering:
Question
The learning in this module
is relevant to my practice.
The learning in this module
will improve the care I
deliver to patients.
This learning promotes
collaboration among
providers.
This learning enhances my
awareness of resources in
my community.

5-Point Likert
Scale

5=Strongly agree
4=Agree,
3=Neutral,
2=Disagree,
1=Strongly
disagree

The author of this module
demonstrates expertise of
the subject matter.

4. How do you feel about this module and eLearning as a method of learning? Please comment.
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Appendix G. Investigational Review Board (IRB) Approval

University of
Massachusetts Amherst
108 Research Administration
Bldg.
70 Butterfield Terrace
Amherst, MA 01003-9242

Human Research Protection Office (HRPO)
Telephone: (413) 545-3428
FAX: (413) 577-1728

Research Compliance

Certification of Human Subjects Approval
Date:

January 17, 2018

To:

Erin Chaney, Nursing

Other Investigator:

Rachel Walker, Nursing

From:

Lynnette Leidy Sievert, Chair, UMASS IRB

Protocol Title: Managing Patients at High Risk for Breast Cancer: A Learning Module for Primary Care Providers (IRB 17-206)
Protocol ID: 2017-4408
Review Type: EXEMPT - NEW
Paragraph ID: 2
Approval Date: 01/17/2018
Expiration Date: 01/16/2021
OGCA #:
This study has been reviewed and approved by the University of Massachusetts Amherst IRB, Federal Wide Assurance # 00003909. Approval is
granted with the understanding that investigator(s) are responsible for:
Modifications - All changes to the study (e.g. protocol, recruitment materials, consent form, additional key personnel), must be submitted for
approval in e-protocol before instituting the changes. New personnel must have completed CITI training.
Consent forms - A copy of the approved, validated, consent form (with the IRB stamp) must be used to consent each subject. Investigators must
retain copies of signed consent documents for six (6) years after close of the grant, or three (3) years if the study is unfunded.
Adverse Event Reporting - Adverse events occurring in the course of the protocol must be reported in e-protocol as soon as possible, but no later
than five (5) working days.
Completion Reports - Notify the IRB when your study is complete by submitting a Final Report Form in e-protocol.
Consent form (when applicable) will be stamped and sent in a separate e-mail. Use only IRB approved copies of the consent forms, questionnaires,
letters, advertisements etc. in your research.
Please contact the Human Research Protection Office if you have any further questions. Best wishes for a successful project.

